Youssef, Gilbert
Wen, Patrick Y.
Article History
Accepted: 27 July 2021
First Online: 20 September 2021
Declarations
:
: Gilbert Youssef declares no potential conflicts of interest. Patrick Y. Wen has received research support from Agios, Astra Zeneca/Medimmune, Bayer, Celgene, Eli Lily, Genentech/Roche, Kazia, MediciNova, Merck, Novartis, Nuvation Bio, Oncoceutics, Vascular Biogenics, and VBI Vaccines. Dr. Wen also serves on the advisory board of Agios, Astra Zeneca, Bayer, Black Diamond, Boston Pharmaceuticals, Elevate Bio, Imvax, Karyopharm, Merck, Mundipharma, Novartis, Novocure, Nuvation Bio, Prelude Therapeutics, Sapience, Vascular Biogenics, VBI Vaccines, Voyager, and QED.
: This article does not contain any studies with human or animal subjects performed by any of the authors.